Chong Ock Lee

1.6k total citations
53 papers, 1.3k citations indexed

About

Chong Ock Lee is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Chong Ock Lee has authored 53 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 21 papers in Organic Chemistry and 18 papers in Oncology. Recurrent topics in Chong Ock Lee's work include Cancer therapeutics and mechanisms (20 papers), Synthesis and biological activity (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Chong Ock Lee is often cited by papers focused on Cancer therapeutics and mechanisms (20 papers), Synthesis and biological activity (9 papers) and Lung Cancer Treatments and Mutations (9 papers). Chong Ock Lee collaborates with scholars based in South Korea, India and United States. Chong Ock Lee's co-authors include Sang Un Choi, Shi Yong Ryu, Chi Hoon Park, Jae Du Ha, Chung Hyo Kang, Jong Yeon Hwang, Ok Pyo Zee, Heung Kyoung Lee, Jong Woong Ahn and Zaesung No and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Chong Ock Lee

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chong Ock Lee South Korea 21 773 310 303 158 122 53 1.3k
Xiaoliang Zheng China 23 625 0.8× 435 1.4× 471 1.6× 180 1.1× 92 0.8× 67 1.5k
Nan Ma China 20 825 1.1× 361 1.2× 287 0.9× 122 0.8× 126 1.0× 90 1.7k
Chung Chui Hong Kong 22 495 0.6× 464 1.5× 199 0.7× 119 0.8× 59 0.5× 50 1.5k
Monica Notarbartolo Italy 26 948 1.2× 216 0.7× 389 1.3× 84 0.5× 51 0.4× 66 1.7k
Indu Parmar Canada 8 648 0.8× 177 0.6× 252 0.8× 74 0.5× 113 0.9× 12 1.2k
David Y. Léger France 25 748 1.0× 170 0.5× 189 0.6× 192 1.2× 228 1.9× 57 1.8k
Walid Fayad Egypt 22 556 0.7× 426 1.4× 213 0.7× 149 0.9× 67 0.5× 57 1.4k
Mrinal Srivastava United States 24 1.5k 2.0× 213 0.7× 546 1.8× 139 0.9× 70 0.6× 46 2.2k
April L. Risinger United States 25 1.1k 1.4× 515 1.7× 491 1.6× 88 0.6× 90 0.7× 78 1.8k
Hong‐Chun Liu China 28 1.5k 1.9× 315 1.0× 212 0.7× 215 1.4× 83 0.7× 96 2.3k

Countries citing papers authored by Chong Ock Lee

Since Specialization
Citations

This map shows the geographic impact of Chong Ock Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong Ock Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong Ock Lee more than expected).

Fields of papers citing papers by Chong Ock Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong Ock Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong Ock Lee. The network helps show where Chong Ock Lee may publish in the future.

Co-authorship network of co-authors of Chong Ock Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Chong Ock Lee. A scholar is included among the top collaborators of Chong Ock Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong Ock Lee. Chong Ock Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Minsung, Suhkneung Pyo, Chung Hyo Kang, et al.. (2018). Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer. PLoS ONE. 13(6). e0198347–e0198347. 79 indexed citations
2.
Kim, Young Hun, Minsung Kim, Ji Eun Kim, et al.. (2018). A natural compound, aristoyagonine, is identified as a potent bromodomain inhibitor by mid-throughput screening. Biochemical and Biophysical Research Communications. 503(2). 882–887. 12 indexed citations
3.
Kang, Chung Hyo, et al.. (2018). Induced protein degradation of anaplastic lymphoma kinase (ALK) by proteolysis targeting chimera (PROTAC). Biochemical and Biophysical Research Communications. 505(2). 542–547. 103 indexed citations
4.
Lee, Chong Ock, et al.. (2017). Novel 2,4-diaminopyrimidines bearing fused tricyclic ring moiety for anaplastic lymphoma kinase (ALK) inhibitor. Bioorganic & Medicinal Chemistry Letters. 27(10). 2185–2191. 11 indexed citations
5.
Kim, Eun Young, Heejung Jung, Chi Hoon Park, et al.. (2016). Discovery of substituted pyrazol-4-yl pyridazinone derivatives as novel c-Met kinase inhibitors. Archives of Pharmacal Research. 39(4). 453–464. 11 indexed citations
6.
Kang, Chung Hyo, Heung Kyoung Lee, Ha-Yeon Lee, et al.. (2016). Replacing the terminal piperidine in ceritinib with aliphatic amines confers activities against crizotinib-resistant mutants including G1202R. European Journal of Medicinal Chemistry. 126. 536–549. 14 indexed citations
7.
Kang, Chung Hyo, Eun Young Kim, Hyoung Rae Kim, et al.. (2016). Minor modifications to ceritinib enhance anti-tumor activity in EML4-ALK positive cancer. Cancer Letters. 374(2). 272–278. 12 indexed citations
8.
Lee, Minji, Chi Hoon Park, Sunjoo Ahn, et al.. (2016). Novel 2,4-diaminopyrimidines bearing tetrahydronaphthalenyl moiety against anaplastic lymphoma kinase (ALK): Synthesis, in vitro, ex vivo, and in vivo efficacy studies. Bioorganic & Medicinal Chemistry Letters. 26(7). 1720–1725. 5 indexed citations
9.
Kang, Chung Hyo, Kwangho Lee, Chong Ock Lee, et al.. (2015). Development of potent ALK inhibitor and its molecular inhibitory mechanism against NSCLC harboring EML4-ALK proteins. Biochemical and Biophysical Research Communications. 464(3). 762–767. 4 indexed citations
10.
Park, Chi-Min, Joo Yun Lee, Jae Du Ha, et al.. (2015). Discovery of novel tetrahydroisoquinoline-containing pyrimidines as ALK inhibitors. Bioorganic & Medicinal Chemistry. 24(2). 207–219. 11 indexed citations
11.
Kim, Eun‐Young, Heejung Jung, Chi Hoon Park, et al.. (2014). Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(21). 5093–5097. 11 indexed citations
12.
Lee, Hyeon Ji, Muhammad Latif, Imran Ali, et al.. (2014). ALK inhibitors of bis-ortho-alkoxy-para-piperazinesubstituted-pyrimidines and -triazines for cancer treatment. Archives of Pharmacal Research. 37(9). 1130–1138. 11 indexed citations
13.
Ryu, Jae Wook, Sun‐Young Han, Sang‐Un Choi, et al.. (2011). Design and synthesis of triazolopyridazines substituted with methylisoquinolinone as selective c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(23). 7185–7188. 17 indexed citations
14.
Zhao, Longxuan, Arjun Basnet, Eun‐Kyung Kim, et al.. (2004). Synthesis, topoisomerase I inhibition and structure–activity relationship study of 2,4,6-trisubstituted pyridine derivatives. Bioorganic & Medicinal Chemistry Letters. 14(5). 1333–1337. 87 indexed citations
15.
Seong, Hasoo, et al.. (2003). BCNU-loaded poly(d, l-lactide-co-glycolide) wafer and antitumor activity against XF-498 human CNS tumor cells in vitro. International Journal of Pharmaceutics. 251(1-2). 1–12. 56 indexed citations
16.
Kim, Ju Sun, Sam Sik Kang, Kun Ho Son, et al.. (2002). Constituents of the fruits and leaves ofEuodia daniellii. Archives of Pharmacal Research. 25(6). 824–830. 59 indexed citations
17.
Jung, Sung Hee, et al.. (2000). 7-(Substituted-phenyl)amino-5,8-isoquinolinediones: Synthesis and cytotoxic activities on cancer cell lines. Medicinal Chemistry Research. 10(1). 40–49. 7 indexed citations
18.
19.
Choi, Sang Un, Chong Ock Lee, Kwang Hee Kim, et al.. (1998). Reversal of multidrug resistance by novel verapamil analogs in cancer cells. Anti-Cancer Drugs. 9(2). 157–166. 20 indexed citations
20.
Kwon, Byoung‐Mog, et al.. (1998). Synthesis andin vitro cytotoxicity of cinnamaldehydes to human solid tumor cells. Archives of Pharmacal Research. 21(2). 147–152. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoliang Zheng Breakdown of academic impact, for papers by Nan Ma Breakdown of academic impact, for papers by Chung Chui Breakdown of academic impact, for papers by Monica Notarbartolo Breakdown of academic impact, for papers by Indu Parmar Breakdown of academic impact, for papers by David Y. Léger Breakdown of academic impact, for papers by Walid Fayad Breakdown of academic impact, for papers by Mrinal Srivastava Breakdown of academic impact, for papers by April L. Risinger Breakdown of academic impact, for papers by Hong‐Chun Liu
Rankless by CCL
2026